Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.

Saved in:
Bibliographic Details
Title: Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy.
Authors: Sami SA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, USA., Darwish NHE; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, USA.; Hematology Unit, Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt., Barile ANM; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, USA., Mousa SA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive, Rensselaer, NY, USA. shaker.mousa@acphs.edu.
Source: Current treatment options in oncology [Curr Treat Options Oncol] 2020 Jan 13; Vol. 21 (1), pp. 3. Date of Electronic Publication: 2020 Jan 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-6277
DOI:10.1007/s11864-019-0694-6